108 related articles for article (PubMed ID: 23810521)
21. Dose assessment for the fetus considering scattered and secondary radiation from photon and proton therapy when treating a brain tumor of the mother.
Geng C; Moteabbed M; Seco J; Gao Y; Xu XG; Ramos-Méndez J; Faddegon B; Paganetti H
Phys Med Biol; 2016 Jan; 61(2):683-95. PubMed ID: 26716718
[TBL] [Abstract][Full Text] [Related]
22. Temporal Trends in Treatment and Subsequent Neoplasm Risk Among 5-Year Survivors of Childhood Cancer, 1970-2015.
Turcotte LM; Liu Q; Yasui Y; Arnold MA; Hammond S; Howell RM; Smith SA; Weathers RE; Henderson TO; Gibson TM; Leisenring W; Armstrong GT; Robison LL; Neglia JP
JAMA; 2017 Feb; 317(8):814-824. PubMed ID: 28245323
[TBL] [Abstract][Full Text] [Related]
23. Radiation-induced malignant meningioma following proton beam therapy for a choroidal melanoma.
Scaringi C; Minniti G; Bozzao A; Giangaspero F; Falco T; Greco A; De Sanctis V; Romano A; Enrici RM
J Clin Neurosci; 2015 Jun; 22(6):1036-7. PubMed ID: 25861886
[TBL] [Abstract][Full Text] [Related]
24. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
25. Editorial comment.
Soloway MS
Urology; 2009 Oct; 74(4):871-2; author reply 872. PubMed ID: 19800511
[No Abstract] [Full Text] [Related]
26. Rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer (Int J Radiat Oncol Biol Phys 2010;76:342-348).
Hyde C
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1607; author reply 1607. PubMed ID: 20637987
[No Abstract] [Full Text] [Related]
27. Comparative treatment planning using secondary cancer mortality calculations.
Schneider U; Lomax A; Lombriser N
Phys Med; 2001; 17 Suppl 1():97-9. PubMed ID: 11770547
[TBL] [Abstract][Full Text] [Related]
28. Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients.
Fortin D; Tsang D; Ng A; Laperriere N; Hodgson DC
J Neurooncol; 2017 Dec; 135(3):521-528. PubMed ID: 28825228
[TBL] [Abstract][Full Text] [Related]
29. Ototoxicity and cochlear sparing in children with medulloblastoma: Proton vs. photon radiotherapy.
Paulino AC; Mahajan A; Ye R; Grosshans DR; Fatih Okcu M; Su J; McAleer MF; McGovern S; Mangona VA; Chintagumpala M
Radiother Oncol; 2018 Jul; 128(1):128-132. PubMed ID: 29373195
[TBL] [Abstract][Full Text] [Related]
30. Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas.
Kuttesch JF; Wexler LH; Marcus RB; Fairclough D; Weaver-McClure L; White M; Mao L; Delaney TF; Pratt CB; Horowitz ME; Kun LE
J Clin Oncol; 1996 Oct; 14(10):2818-25. PubMed ID: 8874344
[TBL] [Abstract][Full Text] [Related]
31. Primary ovarian leiomyosarcoma in an adolescent following radiation for medulloblastoma.
O'Sullivan SG; Das Narla L; Ferraro E
Pediatr Radiol; 1998 Jun; 28(6):468-70. PubMed ID: 9634466
[TBL] [Abstract][Full Text] [Related]
32. Risk of secondary malignancies after radiation therapy for breast cancer: Comprehensive results.
Burt LM; Ying J; Poppe MM; Suneja G; Gaffney DK
Breast; 2017 Oct; 35():122-129. PubMed ID: 28719811
[TBL] [Abstract][Full Text] [Related]
33. Updated Outcome and Analysis of Tumor Response in Mobile Spine and Sacral Chordoma Treated With Definitive High-Dose Photon/Proton Radiation Therapy.
Kabolizadeh P; Chen YL; Liebsch N; Hornicek FJ; Schwab JH; Choy E; Rosenthal DI; Niemierko A; DeLaney TF
Int J Radiat Oncol Biol Phys; 2017 Feb; 97(2):254-262. PubMed ID: 27986348
[TBL] [Abstract][Full Text] [Related]
34. Reducing second breast cancers: a potential role for prophylactic mammary irradiation.
Brenner DJ; Shuryak I; Russo S; Sachs RK
J Clin Oncol; 2007 Nov; 25(31):4868-72. PubMed ID: 17971581
[No Abstract] [Full Text] [Related]
35. Projected second tumor risk and dose to neurocognitive structures after proton versus photon radiotherapy for benign meningioma.
Arvold ND; Niemierko A; Broussard GP; Adams J; Fullerton B; Loeffler JS; Shih HA
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e495-500. PubMed ID: 22285662
[TBL] [Abstract][Full Text] [Related]
36. Proton therapy in the management of lymphoma.
Ho CK; Flampouri S; Hoppe BS
Cancer J; 2014; 20(6):387-92. PubMed ID: 25415683
[TBL] [Abstract][Full Text] [Related]
37. Second malignant neoplasms following treatment for primary cancer.
Somerville HM
Aust Fam Physician; 2003; 32(1-2):25-31. PubMed ID: 12647655
[TBL] [Abstract][Full Text] [Related]
38. Neutrons in active proton therapy: Parameterization of dose and dose equivalent.
Schneider U; Hälg RA; Lomax T
Z Med Phys; 2017 Jun; 27(2):113-123. PubMed ID: 27524678
[TBL] [Abstract][Full Text] [Related]
39. Dosimetric risk estimates of radiation-induced malignancies after intensity modulated radiotherapy.
Patil VM; Kapoor R; Chakraborty S; Ghoshal S; Oinam AS; Sharma SC
J Cancer Res Ther; 2010; 6(4):442-7. PubMed ID: 21358077
[TBL] [Abstract][Full Text] [Related]
40. Wilms tumor and breast cancer.
Lehrer S; Rosenzweig KE
Cancer; 2015 Jun; 121(12):2099. PubMed ID: 25712251
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
